We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
AUM
$4.76B
AUM Growth
+$561M
Cap. Flow
+$284M
Cap. Flow %
5.97%
Top 10 Hldgs %
29.41%
Holding
449
New
22
Increased
185
Reduced
143
Closed
20

Top Sells

Rank Stock Value
1
SYY icon
Sysco
SYY
+$15M
2
MRK icon
Merck
MRK
+$11.8M
3
B
Barrick Mining
B
+$10.3M
4
BSX icon
Boston Scientific
BSX
+$9.6M
5
NDSN icon
Nordson
NDSN
+$3.7M

Sector Composition

Rank Sector Weight
1 Technology 22.35%
2 Healthcare 16.01%
3 Financials 11.88%
4 Industrials 10.97%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.A icon
151
Berkshire Hathaway Class A
BRK.A
$1.12T
$4.14M 0.09%
8
EFA icon
152
iShares MSCI EAFE ETF
EFA
$80.2B
$4.1M 0.09%
56,556
+9,684
+21% +$703K
FSLR icon
153
First Solar
FSLR
$26.9B
$4.04M 0.08%
21,251
-1,132
-5% -$224K
CVS icon
154
CVS Health
CVS
$122B
$4.01M 0.08%
58,024
+516
+0.9% +$36.7K
USB icon
155
US Bancorp
USB
$99.6B
$4M 0.08%
121,099
-16,841
-12% -$544K
FAST icon
156
Fastenal
FAST
$59.5B
$3.96M 0.08%
134,320
-3,494
-3% -$95.6K
VBK icon
157
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.6B
$3.96M 0.08%
17,232
+75
+0.4% +$16.3K
TEL icon
158
TE Connectivity
TEL
$62.6B
$3.93M 0.08%
28,064
-465
-2% -$58.8K
ADI icon
159
Analog Devices
ADI
$190B
$3.85M 0.08%
19,753
-529
-3% -$98K
NVS icon
160
Novartis
NVS
$297B
$3.78M 0.08%
37,429
-250
-0.7% -$25K
WMB icon
161
Williams Companies
WMB
$86.1B
$3.7M 0.08%
113,443
+104,105
+1,115% +$3.12M
KMB icon
162
Kimberly-Clark
KMB
$36.5B
$3.6M 0.08%
26,095
-1,047
-4% -$146K
GILD icon
163
Gilead Sciences
GILD
$165B
$3.59M 0.08%
46,584
+2,405
+5% +$192K
AGCO icon
164
AGCO
AGCO
$7.2B
$3.53M 0.07%
26,891
+21,457
+395% +$2.66M
LFUS icon
165
Littelfuse
LFUS
$11.6B
$3.52M 0.07%
+12,095
New +$3.17M
STT icon
166
State Street
STT
$50.7B
$3.5M 0.07%
47,766
-500
-1% -$35.9K
CME icon
167
CME Group
CME
$94.8B
$3.46M 0.07%
18,700
AMGN icon
168
Amgen
AMGN
$222B
$3.41M 0.07%
15,359
+2,011
+15% +$467K
GIS icon
169
General Mills
GIS
$19.7B
$3.4M 0.07%
44,365
-3,720
-8% -$318K
WFC icon
170
Wells Fargo
WFC
$264B
$3.25M 0.07%
76,183
-1,425
-2% -$57.4K
INTC icon
171
Intel
INTC
$513B
$3.2M 0.07%
95,824
-6,478
-6% -$203K
AZN icon
172
AstraZeneca
AZN
$250B
$3.2M 0.07%
22,332
+18,937
+558% +$2.79M
IJH icon
173
iShares Core S&P Mid-Cap ETF
IJH
$127B
$3.11M 0.07%
59,440
+940
+2% +$46.7K
CMI icon
174
Cummins
CMI
$88.7B
$3.07M 0.06%
12,523
+10,795
+625% +$2.44M
EMR icon
175
Emerson Electric
EMR
$88.3B
$3.01M 0.06%
33,265
-632
-2% -$53.2K

Similar funds

Bradley Foster & Sargent's Q2 2023 Portfolio in Review

As of Q2 2023, Bradley Foster & Sargent held 449 positions worth $4.76B, up 13% from $4.19B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Bradley Foster & Sargent deployed $284M of net new capital in Q2 2023, opening 22 new positions and adding to 185 existing holdings. Its largest new stake was Labcorp: 34,403 shares worth $7.13M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Sysco, an estimated $15M trimmed.

  • Bradley Foster & Sargent's largest Q2 2023 buy was Labcorp: 34,403 shares worth $7.13M.
  • Bradley Foster & Sargent added most to Constellation Brands in Q2 2023, an estimated $38.7M increase.
  • Bradley Foster & Sargent's biggest Q2 2023 reduction was Sysco, cutting an estimated $15M.
  • Bradley Foster & Sargent fully exited Matador Resources in Q2 2023, selling an estimated $1.61M.
  • Bradley Foster & Sargent's ten largest holdings make up 29% of its $4.76B portfolio in Q2 2023.
  • Bradley Foster & Sargent opened 22 new positions and closed 20 in Q2 2023.
  • Bradley Foster & Sargent's portfolio value rose 13% quarter-over-quarter to $4.76B.

Based on Bradley Foster & Sargent's 13F filing for Q2 2023, filed 8 Aug 2023.